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Purpose. To assess the frequency, the pattern of disease causing mutations, and phenotypic variations in patients with Leber
congenital amaurosis (LCA) from Indonesia.
Patients and methods. Twenty-one unrelated index cases with a clinical diagnosis of LCA were screened for mutations in the
coding sequence of RetGC1, RPE65 and AIPL1 gene with single strand conformation polymorphism analysis followed by direct
sequencing and restriction enzyme digestion.
Results. Four novel disease causing mutations were identiﬁed: Three in the RPE65 gene (106del9bp, G32V and Y435C) in two of
21 index cases and one in the AIPL1 (K14E). Two of them were homozygous and one was compound-heterozygous. No disease
causing mutation was identiﬁed in RetGC1.
Conclusions. The four novel disease causing mutations identiﬁed in this study conﬁrmed the diagnosis of LCA which has not been
recognized before in Indonesia. The frequency of RPE65 mutations was 9.5%; and of AIPL1 mutations 4.8%. This was in general
accordance with previous studies reported from other countries. Unlike in those studies, no disease causing RetGC1mutations could
be identiﬁed in our patients. Phenotypically, the RPE65 and AIPL1 mutations identiﬁed in this study caused nearly total blindness
by the second decade of life, but had a diﬀerent onset of symptoms. The patients with the RPE65 mutations retained some useful
visual function until the end of the ﬁrst decade, which progressed to total blindness during the second decade of life, whereas the
(homozygous) AIPL1 mutation was associated with nearly total blindness from infancy on. Therefore, RPE65 mutations have to be
considered to cause early onset severe retinal degeneration (EOSRD), and AIPL1 mutations a form of LCA.
 2003 Elsevier Ltd. All rights reserved.
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Leber congenital amaurosis (LCA, MIM 204000,
204100) is a term used to refer to a group of inherited
retinal dystrophies characterized by severe, bilateral
visual impairment from birth (Leber, 1869). LCA ac-
counts for at least 5% of all retinal dystrophies and is
one of the main causes of blindness in children (Hec-
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gensburg.de (R.S. Sitorus), markus.preising@klinik.uni-regensburg.de
(M.N. Preising).
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doi:10.1016/j.visres.2003.08.008LCA is generally inherited in an autosomal recessive
manner although some autosomal dominant families
have been described. To date, mutations in six genes
have been reported to cause a subset of LCA. These
include GUCY2D or RetGC1, encoding retinal guany-
late cyclase (Perrault et al., 1996); RPE65, encoding a
retinal pigment epithelium-speciﬁc 65 KD protein
(Dharmaraj et al., 2000; Felius et al., 2002; Hamel,
Griﬀoin, Lasquellec, Bazalgette, & Arnaud, 2001;
Lorenz et al., 2000; Lotery et al., 2000; Marcos, Ruiz,
Borrego, & Antinolo, 2001; Marlhens et al., 1998;
Morimura et al., 1998; Poehner et al., 2000; Simovich
et al., 2001; Thompson et al., 2000); CRX, encoding the
cone-rod homeobox-containing gene (Freund et al.,
1997); AIPL1 (Sohocki et al., 2000), CRB1 (Lotery
et al., 2001) and RPGRIP (Dryja et al., 2001). A severe
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LCA has been described with a mutation in the TULP1
gene, encoding the Tubby-like protein 1 (Hagstrom,
North, Nishina, Berson, & Dryja, 1998). The identiﬁ-
cation of these disease causing mutations raised the
possibility of performing speciﬁc genotype–phenotype
correlations that could be used to provide more accurate
diagnostic and prognostic information to the patients.
Ethnic diﬀerences and geographic variations may
aﬀect the frequencies and pattern of mutations. So far
molecular genetic studies of LCA are generally based on
Caucasian populations. As Indonesian ophthalmolo-
gists do not satisfactorily perform the diagnosis of LCA,
no data concerning LCA in Indonesian patients have
been reported before. On the other hand recent data
show that LCA patients carrying defects in the RPE65
gene are expected to be candidates for future therapeutic
trials. Consequently for that reason, characterization of
patients is an important issue to be explored.
There is a need to study this disease in Indonesian
patients by identifying the kind and frequency of se-
quence variations present in the Indonesian population,
performing genotype–phenotype correlations and to
discover new sequence changes with clinical impact.
This study was undertaken to identify and describe
mutations in three genes (RetGC1, RPE65 and AIPL1)
in Indonesian patients with LCA.2. Patients and methods
Twenty-one unrelated individuals from The School
of Blind and Paediatric Ophthalmology Clinic, Cipto
Mangunkusumo Hospital University of Indonesia,
clinically diagnosed by two of the authors (RS and BL)
with LCA were screened for coding sequence mutations
in RetGC1, RPE65 and AIPL1. Electroretinograms
(ERGs) and visual ﬁeld tests could not be performed
due to the limited facilities available.
Blood samples were taken after informed consent
according to The Declaration of Helsinki from aﬀected
individuals and, if available, from their relatives as well.
DNA was extracted from peripheral blood lymphocytes
according to (Miller, Dykes, & Polesky, 1988). DNA
samples were subjected to PCR to amplify the codingTable 1
Probable disease-causing mutations identiﬁed in patients with Leber congen
Case no. Gene Nucleotide Mutation Exon
1 RPE65 106 106del9bpa
homozygous
3
2 RPE65 95 G32Va 3
1304 Y435Ca 12




b Lower case letters indicate intronic sequences.exons of RPE65, RetGC1 and AIPL1 genes using oli-
gonucleotide primers previously reported (RetGC1,
Perrault et al., 1996 and RPE65, Marlhens et al., 1997).
AIPL1 primers have been designed by the authors using
the VECTOR NTI 7.0 Suite (VECTOR NTI Suite 7.0
(2001)). Subsequently, PCR products were analysed
using single strand conformation polymorphism (SSCP)
analysis. The PCR products presenting with aberrant
electrophoretic patterns were subjected to direct se-
quencing using the ﬂuorescent chain termination tech-
nique. To conﬁrm the sequencing result, the PCR
products of the patients, their relatives and controls
were analyzed using restriction endonuclease assay when
possible.3. Results
3.1. Molecular results
We identiﬁed two disease-causing mutations in
RPE65 and one in AIPL1mutation of the 21 index cases
studied. These mutations are summarized in Table 1.
Mutations in RetGC1 were identiﬁed but could not be
proven with any degree of certainty to be disease-caus-
ing. In addition, a number of benign sequence variants
within the RPE65, RetGC1 and AIPL1 genes were
identiﬁed (Table 2). Most of these variants identiﬁed
were intronic.3.2. RPE65 gene mutation
We identiﬁed a homozygous 9 bp in-frame deletion at
nucleotide 106 (106del9bp) predicted to abolish three
amino acids (LWL36del) in case 1 (II:2 in Fig. 1A).
A missense mutation, G32V was identiﬁed in exon 3
of RPE65 in case 2 (II:4 in Fig. 1B) at nucleotide 95.
This mutation aﬀects the ﬁrst base pair of exon 3 and is
considered to have an impact on splicing. The G32V
mutation was conﬁrmed using the TaaI-restriction en-
zyme. In the compound allele, an AﬁG transition at
nucleotide position 1304 in exon 12 was identiﬁed
leading to the substitution of tyrosine by cysteine at
amino acid position 435. The Y435C mutation creates aital amaurosis






Benign sequence variants in Indonesian patients
Variant Base change Exon Allele frequency Previously reported
RPE65
Glu352Glu 1056GﬁA 10 13/44 Morimura et al. (1998)
IVS3-46g/a 246-46GﬁA 4 4/16
IVS6+ 72a/g 643+ 72AﬁG 6 2/8
IVS6-33g/c 645–33GﬁC 7 12/68
IVS12-33a/c 1341–33AﬁC 13 1/8 Marcos et al. (2001)
IVS13+ 45t/c 1450+ 45TﬁC 13 2/8
RetGC1
P701S 2174CﬁT 10 19/50 Dharmaraj et al. (2000)
C457C 1373CﬁT 4 6/6
IVS13+ 74c/t 2576+ 74CﬁT 13 2/2
30UTR 3528TﬁC 20 55/56 Dharmaraj et al. (2000)
AIPL1
L100L 300AﬁG 3 13/22 Sohocki et al. (2000)
P217P 651GﬁA 5 40/66 Sohocki et al. (2000)
IVS2-10a/c 277–10AﬁC 3 29/32 Sohocki et al. (2000)
IVS2-14g/a 277–14GﬁA 3 1/21 Sohocki et al. (2000)
IVS3+ 16g/c 465+ 16GC 3 1/21
IVS3+ 28g/a 465+ 28GﬁA 3 2/21
Fig. 1. (A) Pedigree of Family 1 with case 1 (II:2) shown to carry the
106del9bp mutation in RPE65; (B) pedigree of Family 2 with case 2
(II:4) carrying two mutations in RPE65. Patients available for genetic
testing and clinical examination are indicated by an arrow. (C) TaaI
restriction digest for the heterozygous G32V mutation. The mutation
creates a novel restriction site as shown by the amplimer of II.2 which
shows fragments at 249 and 202 bp; (D)Hpy8I restriction digest for the
heterozygous Y435L mutation. The mutation creates a novel restric-
tion site as shown by the 232 bp restriction fragment of the amplimer
of II.4 which is cut into two fragments of 122 and 101 bp and (E)
fundus photograph of case 2 (II:4) at age 23 years; C––control and
M––marker.
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conﬁrmed by restriction digest.
All three mutations were not present in any of 50
control individuals or in other probands tested.No other family members were available for genetic
testing in both families. So, segregation analysis was not
possible.
3.3. AIPL1 gene mutation
The K14E mutation in AIPL1 is a novel mutation.
The AﬁG substitution at the ﬁrst nucleotide of codon
14 in exon 1 leads to the substitution of a glutamine
residue for a lysine residue. The K14E mutation coseg-
regated in the family in an autosomal recessive pattern.
The K14E mutation creates a new XmnI restriction site
(Fig. 2B). It was not present in any of 60 unaﬀected
individuals or in other probands tested.
3.4. Clinical results
Fig. 1 shows the pedigrees, phenotypes and genotypes
of the families carrying RPE65 mutations. In Fig. 2 the
same data are summarized for the patients carrying the
AIPL1 mutation. Table 3 summarizes the clinical ﬁnd-
ings. Family members available for clinical examination
will be described in the following.
Case 1. The 106del9bp mutation in RPE65 was
identiﬁed in case 1 (II:2 in Fig. 1A), a 21 year-old pa-
tient. She was a child of a consanguineous marriage of
unaﬀected parents, and had two aﬀected brothers. She
had a history of life long severe vision impairment.
When examined at age 21, her visual acuity was re-
stricted to the detection of hand movements in both
eyes. Fine nystagmus was noted and the anterior seg-
ments were normal. Funduscopy showed attenuated
vessels and pigment clumps in the peripheral retina.
Fundus photographs of her were not available.
Fig. 2. (A) Pedigree of Family 3 with AIPL1 mutation K14E. The
index case is indicated by an arrow; (B) XmnI restriction digest for the
homozygous K14E mutation. The mutation creates a novel restriction
site as shown by the restriction fragments of 152 and 103 bp from the
255 bp amplimer; C––control and M––marker. Fundus photograph of
case 3 (II:3) at age 22 years; (C) right eye and (D) left eye.
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G32V/Y435C in RPE65 was found in case 2 (II:4 in Fig.
1B), a 23 year-old male. He completed normal school
until age 9, by which time visual impairment had sig-
niﬁcantly progressed. At the age of 18 severe visual
impairment was diagnosed. At the time of the examin-
ation the visual acuity was limited to light perception in
both eyes. Fine nystagmus was noted, and the anterior
segments were within the normal limit. Funduscopy
showed attenuated retinal vessels, moderate pallor of the
optic disc, areas of pigment epithelium atrophy and
pigment clumps in the mid peripheral retina. In the
macula and the surrounding superotemporal retina is-
lands of marked hyperpigmentations were observed
(Fig. 1E).Table 3
Clinical ﬁndings
Case Age [y] Age at onset [y] Fundus
1 21 >3 Attenuated vessels,
pigment clumps
2 23 9 Fig. 1E
Case 3,
Family 3, 22 Birth Fig. 2C and D
(II:3)
Case 3,
Family 3, 9 Birth Not possible
(II:6)
HM¼Hand movements; LP¼Light perception; OU¼both eyes.Family 3. The homozygous K14E mutation in the
AIPL1 gene was found in a female, 22 years of age (II:3
in Fig. 2A). From birth, the parents of II:3 had noted an
inability to move alone. However, systemic diseases
were absent. Her visual acuity was insuﬃcient to attend
normal school since childhood and at the time of ex-
amination at the age of 22 years her it was restricted to
hand movement and light perception. While the anterior
segments were normal there were attenuated retinal
vessel, hypopigmentation and bone spicule-like pigment
deposits in the midperipheral retina (Fig. 2C/D). The
unrelated parents (I:1 and I:2) were both unaﬀected with
normal anterior segments. While the father presented
with a small macular drusen, the optic nerve head, fovea
and retinal vessels were normal in both eyes. Her sister
aged 6 years (II:6 in Fig. 2A) was aﬀected. The parents
noted that this young girl had a marked visual impair-
ment since birth. She could not follow objects and was
unable to attend the school as a normal child. The
digitoocular sign of Franceschetti (eye poking) was ob-
served. Visual acuity was limited to hand movements in
both eyes, and the anterior segments were normal. Due
to the presence of marked pendular-jerk nystagmus
fundus photography was not possible.4. Discussion
This study is the ﬁrst to be performed in patients from
Indonesia diagnosed with LCA, which has previously
been an under diagnosed, if not disregarded entity in
Indonesia.
The prevalence of causative mutations of RPE65 for
LCA has been estimated from 3.0% to 15.6% (Dhar-
maraj et al., 2000; Lotery et al., 2000; Morimura et al.,
1998; Simovich et al., 2001) although early and recurring
reports have already put forward that RPE65 mutations
cause an early onset severe retinal degeneration
(EOSRD) which is phenotypically diﬀerent from LCA
(Gu et al., 1997; Lorenz et al., 2000; Thompson et al.,
2000). The important diﬀerence of EOSRD and LCA is a
signiﬁcantly better initial visual performance in EOSRDNystagmus Visual acuity Consanguinity
+, mild-moderate HM, OU Yes
+, mild-moderate LP, OU No
+, severe HM, LP No
+, pendular-jerk HM, OU No
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schools until the early teen years. AIPL1 mutations were
identiﬁed in 7–9% of LCA cases worldwide.
Our study was performed on a small set of index
cases. The frequencies of mutations identiﬁed in RPE65
(9.5%) and in AIPL1 (4.8%) are in general accordance
with previous studies (Dharmaraj et al., 2000; Lotery
et al., 2000; Morimura et al., 1998; Simovich et al., 2001;
Sohocki et al., 2000). Our ﬁndings, however, were in
contrast with a study in the Indian population, which
reported that RPE65 seems to be less involved in the
causation of LCA (Joseph et al., 2002). All index cases
carrying the mutations were students at a School for
Blind in Bandung with a total number of about 200
blind persons caused by diﬀerent etiologies. Most of
them come from West Java region with a total popula-
tion of 35,000,611 in an area of 44,355 km2.
4.1. RPE65 mutations
The precise role of RPE65 has not been determined,
however, it is clear that the protein has a crucial role in
the metabolism of vitamin A in the visual cycle (Red-
mond et al., 1998). Regeneration of the visual pigment is
performed in the RPE, and requires the isomerisation of
all trans-retinol to 11-cis-retinol, followed by the oxi-
dation to 11-cis-retinal. In the absence of RPE65, the
isomerisation process is blocked, leading to an accu-
mulation of all-trans-retinyl esters (Redmond et al.,
1998). The distribution of disease causing mutations
may be useful in identifying important functional do-
mains. A most complete collection of RPE65 mutations
can be obtained from the World Wide Web (http://
www.retina-international.org/sci-news/rpe65mut.htm).
The 106del9bp mutation in index case 1 has not been
reported previously. It predicts an in-frame mutation
and synthesis of a polypeptide shortened by three amino
acids L36, W37 and L38. The amino acids W37 and L38
are conserved throughout the vertebrates from Homo-
sapiens down to the Japanese ﬁrebelly newt Cynops
pyrrogaster, whereas L36 is not. It is very likely that
106del9bp is predicting a functional null allele.
The compound heterozygous mutation G32V/Y435C
identiﬁed in case 2 cannot be evaluated according to the
aﬀected protein domains since no domains have been
described in RPE65. However, Gly 32 and Tyr 435 are
conserved residues throughout the vertebrates from
Homosapiens down to the Japanese ﬁrebelly newt
Cynops pyrrogaster. It is presumed therefore, that these
substitutions will lead to functional null alleles.
Correlations between LCA genotypes and the disease
severity have been established for patients with RetGC1
(LCA1) and RPE65 mutations (LCA2) (Dharmaraj
et al., 2000; Dharmaraj et al., 2000; Perrault et al., 1999).
Several publications reported homozygous or com-
pound heterozygous RPE65 mutations associated withcases of EOSRD (Felius et al., 2002; Gu et al., 1997;
Lorenz et al., 2000). In this present study a preserved
visual function up to the age of about 9 years was noted
in cases carrying RPE65 mutations, which afterwards
progressed to almost total blindness during the second
decade of life. Unfortunately we could not get any de-
tailed information concerning the visual performance of
these patients in early childhood as described by another
studies (Lorenz et al., 2000). It is suggested that visual
performance might be better during the ﬁrst year of life,
which may reﬂect postnatal physiological cone matura-
tion (Lorenz et al., 2000).
Clinical characterisation of mutations in RPE65 and
other RPE expressed genes involved in retinol metabo-
lism suggest that impairment of the ocular metabolism
of retinol predominantly aﬀects rods (Hamel et al.,
2001). Our ﬁndings are in agreement with a mutation of
RPE65 resulting in degeneration of the macular as
previously suggested, as changes in the macular may
reﬂect the greater density of rods over cones at the pe-
riphery of the macula.
4.2. AIPL1 mutations
AIPL1 has been reported to cause LCA4 (Sohocki
et al., 2000). It is a cytoplasmic protein with similarities
to aryl hydrocarbon receptor-interacting protein (AIP),
a member of the FK-506-binding protein family. It
contains three tetratricopeptide repeats (TPR), a motif
that is found in proteins with nuclear transport or pro-
tein chaperone activity, suggesting that AIPL1 may be
involved in retinal protein folding or traﬃcking (So-
hocki et al., 2000). However, the exact function of
AIPL1 remains unknown. Only a few data on AIPL1
mutations providing detailed clinical information were
reported so far. In the present study cases II:3 and II:6
(Family 3) are homozygous for a K14E mutation. Ly-
sine at this position is highly conserved in human, rat
and mouse. It is likely, therefore, that this substitution
represents a disease causing-mutation in this family.
Our data suggest that AIPL1 mutations cause a se-
vere, early-onset blindness, a condition that can be dis-
tinguished from blindness in patients with the RPE65
mutation (LCA2). In both aﬀected index cases (II:3 and
II:6 in Family 3) total blindness was noted from infancy
onwards. Pendular-jerk nystagmus and eye poking
conﬁrmed a severe perturbation of the development of
visual function during the early stages of life. The severe,
early-onset of blindness was also observed in our sepa-
rated study in Caucasian patients harboring AIPL1
mutations (manuscript in preparation). This severe early
onset of blindness may be due to a defect in the regu-
lation of cell cycle progression during photoreceptor
maturation. Thus, our data support that AIPL1 plays a
role during early retinal development. It has been hy-
pothesized that this gene is important in cytosolic
3092 R.S. Sitorus et al. / Vision Research 43 (2003) 3087–3093stability and/or nuclear transport of NUB1 during reg-
ulation of cell cycle progression during photoreceptor
maturation (Akey et al., 2002).
The phenotype of AIPL1 mutations might be vari-
able. Recently, it was reported that mutations in AIPL1
cause autosomal dominant cone-rod dystrophy (So-
hocki et al., 2000). AIPL1 mutations in our case segre-
gated in an autosomal recessive pattern. Concerning the
progression we were not able to distinguish between
cone-rod and rod-cone progression. Indeed recent re-
sults by van der van der Spuy et al. (2002) indicate a rod-
speciﬁc expression of AIPL1 which argues against a
cone-rod progression.
As AIPL1 and RetGC1 were assigned closely on
17p13, both AIPL1 and RetGC1 should be screened for
mutations in families with aﬀected individuals whose
LCA locus maps to 17p13, or in families with aﬀected
individuals who are homozygous for mutations in either
gene, unless linkage excludes one of the genes by intra-
genic markers (Sohocki et al., 2000). In our study the
presence of RetGC1 mutation could be excluded by the
mutational screening.
4.3. RetGC1 mutations
Mutations in RetGC1 gene have been identiﬁed in a
large number of LCA families with the mutation fre-
quency of 6.0–20.3% (Lotery et al., 2000). (Dharmaraj
et al., 2000; Perrault et al., 2000) Our study could not
identify any disease causing mutations in RetGC1, de-
spite having screened the entire open reading frame of
the gene. This may be due to the diﬀerence in the ethnic
background between Indonesian patients and previously
studied populations that had been recruited from
countries surrounding the Mediterranean Sea (Hanein
et al., 2002). This introduces a bias in studies on patients
from elsewhere.
In the present study we identiﬁed a frequent mutation
(P701S) in 19 of 50 alleles in the heterozygote state in-
cluding case 2, in whom a compound heterozygote
RPE65 mutation was identiﬁed as disease-causing mu-
tation. The P701S was reported previously as sequence
variant which did not co-segregate with both of the af-
fected probands in the family, but was detected only in
the worse aﬀected sibling in the pedigree (Dharmaraj
et al., 2000). Further studies will be necessary to conﬁrm
whether this variation signiﬁcantly alters the protein
activity and how its interaction with other genes is in-
volved in the pathogenesis of the disease.
In summary, the disease causing mutations identiﬁed
in this study conﬁrmed the diagnosis of LCA2 and
LCA4, which has not been well described before in In-
donesian patients. Phenotypically all the RPE65 and
AIPL1 mutations identiﬁed caused total or almost total
blindness in the second to third decade of life, but the
onset of the blindness was considerably diﬀerent. Pa-tients with RPE65 mutation retain useful visual func-
tions until the ﬁrst decade, which is progressing to total
blindness in the second to third decade of life. The pa-
tient with the AIPL1 mutation suﬀered from almost
complete impairment of vision since birth. It is neces-
sary, however, to conduct molecular screening studies in
a larger scale on extended Indonesian families, to allow
better recognition of pathogenicity of certain alleles and
genotype–phenotype correlations.Acknowledgements
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